featured
Delayed Immune-Related Adverse Events With Anti–PD-1–Based Immunotherapy in Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology